Labiana, the pharmaceutical laboratory specialized in animal and human health listed on BME Growth, has added Lexylan, a new antibiotic classified as Category C in its prescription guidelines, to its product portfolio.
Labiana, el primer laboratorio veterinario español cotizado en Bolsa, ha reforzado su división especializada en pequeños animales.